CSF(600654)

Search documents
中安科涨2.07%,成交额1.41亿元,主力资金净流入642.39万元
Xin Lang Cai Jing· 2025-09-11 06:42
中安科今年以来股价涨6.81%,近5个交易日涨2.07%,近20日涨4.23%,近60日涨23.66%。 今年以来中安科已经1次登上龙虎榜,最近一次登上龙虎榜为8月6日,当日龙虎榜净买入-1161.65万 元;买入总计7409.20万元 ,占总成交额比15.28%;卖出总计8570.85万元 ,占总成交额比17.68%。 资料显示,中安科股份有限公司位于湖北省武汉市武昌区紫沙路203号华中小龟山金融文化公园5栋,成 立日期1991年12月31日,上市日期1990年12月19日,公司主营业务涉及安保系统集成、安保运营服务及 物联网产品制造。主营业务收入构成为:安保运营服务66.03%,智慧城市系统集成27.76%,安保智能 产品制造5.88%,租赁0.31%,其他0.02%。 9月11日,中安科盘中上涨2.07%,截至14:04,报3.45元/股,成交1.41亿元,换手率1.79%,总市值99.24 亿元。 截至6月30日,中安科股东户数11.62万,较上期减少8.66%;人均流通股19881股,较上期增加10.01%。 2025年1月-6月,中安科实现营业收入15.54亿元,同比增长18.24%;归母净利润2 ...
中安科2025年中报简析:增收不增利,公司应收账款体量较大
Zheng Quan Zhi Xing· 2025-08-30 23:26
Core Viewpoint - Zhong An Ke (600654) reported mixed financial results for the first half of 2025, with significant revenue growth but a drastic decline in net profit, raising concerns about its financial health and operational efficiency [1][2]. Financial Performance - Total revenue for the first half of 2025 reached 1.554 billion yuan, an increase of 18.24% year-on-year [1]. - Net profit attributable to shareholders was 2.5154 million yuan, a decrease of 89.97% compared to the previous year [1]. - In Q2 2025, total revenue was 808 million yuan, up 14.98% year-on-year, while net profit was -6.0659 million yuan, down 214.44% [1]. Profitability Metrics - Gross margin stood at 15.38%, down 3.48% year-on-year [1]. - Net margin was only 0.16%, reflecting a significant decline of 91.53% [1]. - The company's return on invested capital (ROIC) was 2.11%, indicating weak capital returns [2]. Cost and Expense Analysis - Total selling, administrative, and financial expenses amounted to 203 million yuan, accounting for 13.05% of revenue, a decrease of 17.09% year-on-year [1]. - The company has a high accounts receivable ratio, with accounts receivable reaching 3064.89% of net profit [1][2]. Cash Flow and Financial Health - Cash flow from operations per share was -0.0 yuan, a decrease of 108.47% year-on-year [1]. - The company's cash and cash equivalents decreased by 9.79% to 614 million yuan [1]. - The ratio of cash to current liabilities was only 62.71%, indicating potential liquidity issues [2]. Historical Performance - The company has reported a median ROIC of 0.76% over the past decade, with six years of losses since its IPO [1][2].
中安科上半年实现营收15.54亿元,净利润同比暴跌89.98%
Ju Chao Zi Xun· 2025-08-30 02:14
n 7 p RTL e ring t 4 d 1995 7 Ale N P r al Aller 5 r 3 / 20 202 D 截至上半年末,中安科总资产为3,714,476,165.92元,同比增长1.75%;归属于上市公司股东的净资产为1,687,739,831.21元,同比增长1.82%。 | | | | 单位:元 币种:人民币 | | --- | --- | --- | --- | | 主要会计数据 | 本报告期 | 上年同期 | 本报告期比上年 | | | (1-6月) | | 同期增减(%) | | 营业收入 | 1.553.902.716.10 | 1.314.166.541.90 | 18.24 | | 利润息额 | 16,247,783.02 | 31.844.850.76 | -48.98 | | 归属于上市公司股东的净利润 | 2.515.366.29 | 25,091,004.21 | -89.98 | | 归属于上市公司股东的扣除非经常性 | 3.878.828.83 | -12.920.665.72 | 不适用 | | 损益的净利润 | | | | | 经营活动产生的现金流量净 ...
中安科股份有限公司2025年半年度报告摘要
Shang Hai Zheng Quan Bao· 2025-08-29 20:21
Core Viewpoint - The company has released its 2025 semi-annual report, which includes financial data and the status of fundraising activities, ensuring compliance with regulatory requirements [1][4][11]. Company Overview - The company is identified as 中安科 (Zhong An Ke), with the stock code 600654 [1]. - The report emphasizes the importance of reviewing the full semi-annual report for a comprehensive understanding of the company's performance and future plans [1]. Financial Data - The company raised a total of approximately RMB 952.99 million through a non-public offering of 131,994,459 shares at an issue price of RMB 7.22 per share [11]. - After deducting issuance costs of about RMB 19.06 million, the net proceeds amounted to approximately RMB 933.94 million [11]. - As of June 30, 2025, the company had invested approximately RMB 902.66 million of the raised funds, with a remaining balance of RMB 59,951.80 [12]. Board Meeting - The 12th Board of Directors held its fifth meeting on August 29, 2025, with all nine directors present, and the meeting adhered to legal and procedural requirements [3][6]. - The board approved the semi-annual report and the special report on the use of raised funds, confirming that these documents had been reviewed by the audit committee prior to the meeting [4][7]. Fundraising Management - The company has established a management framework for the raised funds, ensuring compliance with relevant laws and regulations [13]. - A four-party supervision agreement was signed with banks to manage the raised funds, ensuring proper oversight [14]. Fund Usage - No funds were used to replace pre-invested capital in the first half of 2025, and there were no investments made with idle funds during this period [16][18]. - The company had previously approved the temporary use of RMB 37 million of idle funds to supplement working capital, but due to account freezes, the funds were not returned as scheduled [17][21]. Issues and Compliance - The company has been actively addressing issues related to the temporary use of idle funds and is exploring solutions to resolve historical problems and related litigation [21]. - The company asserts that all disclosed information regarding the use of raised funds is timely, truthful, accurate, and complete, with no violations of regulatory requirements [21].
中安科:2025年半年度净利润约252万元
Mei Ri Jing Ji Xin Wen· 2025-08-29 17:33
Company Performance - Zhong An Ke (SH 600654) reported a revenue of approximately 1.554 billion yuan for the first half of 2025, representing a year-on-year increase of 18.24% [1] - The net profit attributable to shareholders was approximately 2.52 million yuan, showing a significant year-on-year decrease of 89.98% [1] - Basic earnings per share were 0.0009 yuan, which is a decline of 89.89% compared to the previous year [1] Industry Context - The domestic A-class car exhibition, featuring nearly 120 brands and 1,600 vehicles, is set to open in the southwest, indicating a competitive landscape in the automotive market [1] - The emergence of new energy vehicles is expected to reshape the market dynamics, referred to as the "third pole" in the industry [1]
中安科6月30日股东户数11.62万户,较上期减少8.66%
Zheng Quan Zhi Xing· 2025-08-29 10:23
从股价来看,2025年3月31日至2025年6月30日,中安科区间跌幅为8.05%,在此期间股东户数减少1.1万 户,减幅为8.66%。 证券之星消息,近日中安科披露,截至2025年6月30日公司股东户数为11.62万户,较3月31日减少1.1万 户,减幅为8.66%。户均持股数量由上期的2.26万股增加至2.47万股,户均持股市值为7.35万元。 在软件开发行业个股中,中安科股东户数高于行业平均水平,截至6月30日,软件开发行业平均股东户 数为4.98万户。户均持股市值方面,软件开发行业A股上市公司户均持股市值为26.84万元,中安科低于 行业平均水平。 | | | | 统计截止日|区间股价涨跌幅|股东户数| 增减 增减比例|户均持股市值(元)|户均持股数(股) | | | | | --- | --- | --- | --- | --- | --- | --- | | 2025-06-30 | -8.05% | 116235 -11020 | | -8.66% | 7.35万 | 2.47万 | | 2025-03-31 | 0.00% | 127255 | -4332 | -3.29% | 7.30万 | ...
中安科(600654.SH)上半年净利润251.54万元,同比下降89.98%
Ge Long Hui A P P· 2025-08-29 10:09
Group 1 - The company reported a revenue of 1.554 billion yuan for the first half of 2025, representing a year-on-year increase of 18.24% [1] - The net profit attributable to shareholders of the listed company was 2.5154 million yuan, showing a significant year-on-year decline of 89.98% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 3.8788 million yuan, with basic earnings per share of 0.0009 yuan [1]
中安科(600654) - 第十二届董事会第五次会议决议公告
2025-08-29 10:04
证券代码:600654 证券简称:中安科 公告编号:2025-067 2025 年半年度报告及摘要中的财务信息在提交董事会审议前,已经公司董 事会审计委员会审议通过。 公司 2025 年半年度报告全文及摘要详见 2025 年 8 月 30 日上海证券交易所 网站(www.sse.com.cn)。 表决情况:9 票同意,0 票反对,0 票弃权。 中安科股份有限公司 第十二届董事会第五次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 中安科股份有限公司(以下简称"公司")第十二届董事会第五次会议于 2025 年 8 月 29 日以现场结合通讯表决方式召开。会议通知于 2025 年 8 月 19 日 以电话、电子邮件方式向全体董事发出。本次会议应到董事 9 人,实到董事 9 人。本次会议由吴博文先生主持。本次会议的召集、召开及表决程序符合《公司 法》和《公司章程》的规定。 二、董事会会议审议情况 经与会董事表决,会议审议通过如下决议: (一)审议通过《关于公司 2025 年半年度报告全文及摘要的 ...
中安科(600654) - 2025 Q2 - 季度财报
2025-08-29 09:05
中安科股份有限公司2025 年半年度报告 公司代码:600654 公司简称:中安科 中安科股份有限公司 2025 年半年度报告 1 / 217 √适用 □不适用 本半年度报告涉及的发展战略、未来计划等前瞻性陈述,不构成公司对投资者的实质承诺, 请投资者注意投资风险。 七、 是否存在被控股股东及其他关联方非经营性占用资金情况 二、 公司全体董事出席董事会会议。 三、 本半年度报告未经审计。 四、 公司负责人吴博文、主管会计工作负责人李翔及会计机构负责人(会计主管人员)李伟声 明:保证半年度报告中财务报告的真实、准确、完整。 五、 董事会决议通过的本报告期利润分配预案或公积金转增股本预案 无 六、 前瞻性陈述的风险声明 中安科股份有限公司2025 年半年度报告 重要提示 一、 本公司董事会及董事、高级管理人员保证半年度报告内容的真实性、准确性、完整性,不 存在虚假记载、误导性陈述或重大遗漏,并承担个别和连带的法律责任。 否 八、 是否存在违反规定决策程序对外提供担保的情况 否 九、 是否存在半数以上董事无法保证公司所披露半年度报告的真实性、准确性和完整性 否 十、 重大风险提示 本报告已详细描述存在的市场风险、技 ...
中安科(600654) - 2025年半年度募集资金存放及实际使用情况专项报告
2025-08-29 09:01
证券代码:600654 证券简称:中安科 公告编号:2025-068 中安科股份有限公司 2025 年半年度募集资金存放及实际使用情况 专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 中安科股份有限公司(以下简称"公司")董事会根据中国证券监督管理委 员会《上市公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求》 及《上海证券交易所上市公司自律监管指引第 1 号——规范运作》及相关格式指 引的规定,编制了截至 2025 年 6 月 30 日的非公开发行 A 股股票募集资金存放 与实际使用情况的专项报告(以下简称"募集资金存放与实际使用情况报告")。 具体如下: 一、募集资金基本情况 经中国证券监督管理委员会证监发行字〔2014〕1393 号文核准,并经上海 证券交易所同意,本公司由主承销商招商证券股份有限公司以非公开发行股票方 式发行人民币普通股(A 股)股票 131,994,459 股,每股面值 1 元,每股发行价 人民币 7.22 元。公司共募集资金 952,999,993.98 元,扣除发行费用 1 ...